Display Settings:

Format

Send to:

Choose Destination
    Int J Cancer. 2008 Jul 15;123(2):365-71.

    Silencing of hSlo potassium channels in human osteosarcoma cells promotes tumorigenesis.

    Source

    Université de Nice Sophia Antipolis, UFR Sciences, Nice F-06002, France.

    Erratum in

    • Int J Cancer. 2008 Sep 15;123(6):1481. Soilihi, Babou Karimdjee [corrected to Karimdjee, Babou Soilihi].

    Abstract

    Potassium channels, the most diverse superfamily of ion channels, have recently emerged as regulators of carcinogenesis, thus introducing possible new therapeutic strategies in the fight against cancer. In particular, the large conductance Ca(2+)-activated K(+) channels, often referred to as BK channels, are at the crossroads of several tumor-associated processes such as cell proliferation, survival, secretion and migration. Despite the high BK channel expression in osteosarcoma (OS), their function has not yet been investigated in this malignant bone pathology. Here, using stable RNA interference to reduce the expression of hSlo, the human pore-forming alpha-subunit of the BK channel, in human Cal72 OS cells, we show that BK channels play a functional role in carcinogenesis. Our results reveal for the first time that BK channels exhibit antitumoral properties in OS in vivo and affect the tumor microenvironment through the modulation of both chemokine expression and leukocyte infiltration.

    (c) 2008 Wiley-Liss, Inc.

    PMID:
    18404672
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for John Wiley & Sons, Inc.

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk